↓ Skip to main content

Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States

Overview of attention for article published in PharmacoEconomics, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
70 Mendeley